Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of Dopamine in the Central Neural Signature of Chronic Pain
NCT05285683Phase 2Recruiting
- Sponsor
- University of Rochester
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet, carbidopa + levodopa in chronic pain, sponsored by University of Rochester. Started Jan 2024; status: recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tabletcarbidopa + levodopa
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT05285683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05285683.